Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02141828
Title A Phase 1 Dose Escalation and Expanded Cohort Study of EPZ-5676 in the Treatment of Pediatric Patients With Relapsed/Refractory Leukemias Bearing a Rearrangement of the MLL Gene
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Epizyme, Inc.
Age Groups: child
Covered Countries USA | CAN

Additional content available in CKB BOOST